Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients
暂无分享,去创建一个
E. Shin | H. Sung | D. Han | Sung-Han Kim | Taeeun Kim | Sun-mi Kim | Y. Kim | S. Shin | J. Kwon
[1] S. Choi,et al. Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[2] G. Palù,et al. Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot Assay but Not CMV QuantiFERON Assay Is a Novel Biomarker To Determine Risk of Congenital CMV Infection in Pregnant Women , 2016, Journal of Clinical Microbiology.
[3] S. Choi,et al. Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy , 2016, The Korean journal of internal medicine.
[4] Cliburn Chan,et al. Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation. , 2016, American journal of respiratory and critical care medicine.
[5] G. Palù,et al. Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated With Increased Risk of Fetal Infection in Primarily Infected Pregnant Women. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] P. Reinke,et al. The Loss of BKV‐specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] L. Biancone,et al. Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients. , 2015, The new microbiologica.
[8] S. Choi,et al. Diagnostic Usefulness of Cytomegalovirus (CMV)-Specific T Cell Immunity in Predicting CMV Infection after Kidney Transplantation: A Pilot Proof-of-Concept Study , 2015, Infection & chemotherapy.
[9] R. Solana,et al. Pretransplant Interferon‐γ Secretion by CMV‐Specific CD8+ T Cells Informs the Risk of CMV Replication After Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] G. Gerosa,et al. Human Cytomegalovirus-Specific T-Cell Immune Reconstitution in Preemptively Treated Heart Transplant Recipients Identifies Subjects at Critical Risk for Infection , 2012, Journal of Clinical Microbiology.
[11] M. del Río,et al. Dynamics of cell‐mediated immune responses to cytomegalovirus in pediatric transplantation recipients , 2012, Pediatric transplantation.
[12] Deepali Kumar,et al. Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia , 2012, Transplantation.
[13] S. Choi,et al. A Prospective Longitudinal Study Evaluating the Usefulness of a T‐Cell‐Based Assay for Latent Tuberculosis Infection in Kidney Transplant Recipients , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] S. Baldi,et al. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients. , 2011, Transplantation proceedings.
[15] I. Lochman,et al. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation. , 2010, Transplantation proceedings.
[16] T. Lazzarotto,et al. Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. , 2010, Transplantation proceedings.
[17] C. Huber,et al. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[18] T. Kotsimbos,et al. Linking CMV Serostatus to Episodes of CMV Reactivation Following Lung Transplantation by Measuring CMV‐Specific CD8+ T‐Cell Immunity , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] F. Prósper,et al. Qualitative Plasma PCR Assay (AMPLICOR CMV Test) versus pp65 Antigenemia Assay for Monitoring Cytomegalovirus Viremia and Guiding Preemptive Ganciclovir Therapy in Allogeneic Stem Cell Transplantation , 2001, Journal of Clinical Microbiology.